Work

Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix

Year: 2020

Type: article

Study design: Observational Study

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2020-001649

Authors: Matthew Ryan Carroll, Preetha Ramalingam, Gloria Salvo, Junya Fujimoto, Luisa Maren Solis Soto, Natacha Phoolcharoen, Robert Tyler Hillman, Robert Cardnell, Lauren Byers, Michael Frumovitz

Institutions: Baylor College of Medicine, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: LUNGevity Foundation, Eli Lilly and Company, AstraZeneca, BioMarin Pharmaceutical, Stryker, Astex Pharmaceuticals, Ipsen, National Institutes of Health, National Cancer Institute

Awards: G1135378803, G1386998783, G9000006196, G9000077497, G9000108460, G9000112290, G988756546, G995644284

OpenAlex ID: W3046464075

FWCI: 4.133

Cites: 36

Cited by: 45

Related to: 10